Foley Partner Judy Waltz, Co-Chair of the firm’s Health Care Industry Team, will be presenting at the 2021 Rx Pricing and Reimbursement Summit on Monday May 24th at 2:30 p.m. EST. Her presentation is titled, “Analyze Newly Developed Federal Pricing Transparency Laws in Public Payor Programs.” In November 2020, HHS released a final rule requiring health insurers to disclose drug pricing costs, as well as cost-sharing information to participants in their plans. Are you prepared to comply with these changes in transparency requests?
In this program, Ms. Waltz will explore the tool which insurers must develop to provide patients with an out-of-pocket estimate, examine the effect of the rule on negotiations between manufactures, PMBs, and health insurers, and discuss the exemption to the rule for Medicaid and Medicare.
